CCM
LIAN

CAAS Capital Management’s LianBio American Depositary Shares LIAN Stock Holding History

CAAS Capital Management’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-44,432
Closed -$274K – 1006
2021
Q4 		$274K Buy
+44,432
New +$507K 0.01% 628

Other funds holding LIAN

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CAAS Capital Management's LIAN Position: Q1 2022 in Review

CAAS Capital Management sold out of LianBio American Depositary Shares (LIAN) in Q1 2022, closing a stake of 44,432 shares — an estimated $274K sold.

CAAS Capital Management first reported a position in LIAN in Q4 2021 and held it in 1 quarter. The position peaked at $274K in Q4 2021. 37 funds tracked by Wall St. Rank hold LIAN as of Q1 2022.

  • CAAS Capital Management reported no remaining LianBio American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • CAAS Capital Management sold 44,432 LianBio American Depositary Shares shares in Q1 2022, an estimated $274K.
  • CAAS Capital Management first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • CAAS Capital Management's LianBio American Depositary Shares position peaked at $274K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2022.

Based on CAAS Capital Management's 13F filing for Q1 2022, filed 13 May 2022.